(Q35034312)

5 August 2017

title

High dose D-serine in the treatment of schizophrenia (English)

1 reference

5 August 2017

0 references

1 reference

10

Daniel C Javitt

1 reference

5 August 2017

Joshua T Kantrowitz

1

1 reference

5 August 2017

Anil K Malhotra

2

1 reference

5 August 2017

Barbara Cornblatt

3

1 reference

5 August 2017

Gail Silipo

4

1 reference

5 August 2017

Andrea Balla

5

1 reference

5 August 2017

Raymond F Suckow

6

1 reference

5 August 2017

Cyril D'Souza

7

1 reference

5 August 2017

John Saksa

8

1 reference

5 August 2017

Scott W Woods

9

1 reference

5 August 2017

language of work or name

English

0 references

publication date

11 June 2010

1 reference

5 August 2017

published in

Schizophrenia Research

1 reference

5 August 2017

volume

121

1 reference

5 August 2017

issue

1-3

1 reference

5 August 2017

page(s)

125-130

1 reference

Tardive dyskinesia and new antipsychotics

5 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111070

Glycine transport inhibitors and the treatment of schizophrenia

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111070

Glycine and D-cycloserine attenuate vacuous chewing movements in a rat model of tardive dyskinesia

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111070

Chlorpromazine equivalent doses for the newer atypical antipsychotics

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111070

Specificity of the Calgary Depression Scale for schizophrenics.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111070

Negative symptoms in schizophrenia. Definition and reliability

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111070

A rating scale for extrapyramidal side effects

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111070

The positive and negative syndrome scale (PANSS) for schizophrenia

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111070

A rating scale for drug-induced akathisia

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111070

Recent advances in the phencyclidine model of schizophrenia

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111070

The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111070

Relation of plasma glycine, serine, and homocysteine levels to schizophrenia symptoms and medication type

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111070

Comparative effects of glycine and D-cycloserine on persistent negative symptoms in schizophrenia: a retrospective analysis

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111070

Plasma glycine and serine levels in schizophrenia compared to normal controls and major depression: relation to negative symptoms

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111070

Determination of free amino acid enantiomers in rat brain and serum by high-performance liquid chromatography after derivatization with N-tert.-butyloxycarbonyl-L-cysteine and o-phthaldialdehyde

25 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20541910

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.SCHRES.2010.05.012

1 reference

5 August 2017

1 reference

5 August 2017

1 reference